Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Odde

Showing results (111-120 of 120) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 120 results.
Biorxiv : the Preprint Server for Biology|October 3, 2025
Differential migration mechanics and immune responses of glioblastoma subtypesGhaidan A Shamsan, Chao J Liu, Brooke C Braman, et al.
Molecular Biology of the Cell|April 7, 2017
Integrin-mediated traction force enhances paxillin molecular associations and adhesion dynamics that increase the invasiveness of tumor cells into a three-dimensional extracellular matrixArmen H Mekhdjian, FuiBoon Kai, Matthew G Rubashkin, et al.
Medrxiv : the Preprint Server for Health Sciences|January 4, 2023
Outpatient treatment of Covid-19 with metformin, ivermectin, and fluvoxamine and the development of Long Covid over 10-month follow-upCarolyn T Bramante, John B Buse, David Liebovitz, et al.
Open Forum Infectious Diseases|April 8, 2022
Vaccination Against SARS-CoV-2 Is Associated With a Lower Viral Load and Likelihood of Systemic SymptomsCarolyn T Bramante, Jennifer L Proper, David R Boulware, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 20, 2022
Impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccination and Booster on Coronavirus Disease 2019 (COVID-19) Symptom Severity Over Time in the COVID-OUT TrialDavid R Boulware, Thomas A Murray, Jennifer L Proper, et al.
Cancer Research|January 25, 2019
<i>Sleeping Beauty</i> Insertional Mutagenesis Reveals Important Genetic Drivers of Central Nervous System Embryonal TumorsPauline J Beckmann, Jon D Larson, Alex T Larsson, et al.
The Lancet. Infectious Diseases|June 11, 2023
Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trialCarolyn T Bramante, John B Buse, David M Liebovitz, et al.
The New England Journal of Medicine|September 7, 2022
Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19Carolyn T Bramante, Jared D Huling, Christopher J Tignanelli, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 2024
Favorable Antiviral Effect of Metformin on SARS-CoV-2 Viral Load in a Randomized, Placebo-Controlled Clinical Trial of COVID-19Carolyn T Bramante, Kenneth B Beckman, Tanvi Mehta, et al.
Medrxiv : the Preprint Server for Health Sciences|June 19, 2023
Metformin reduces SARS-CoV-2 in a Phase 3 Randomized Placebo Controlled Clinical TrialCarolyn T Bramante, Kenneth B Beckman, Tanvi Mehta, et al.
Pageof 12

Showing results (111-120 of 120) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 120 results.
Biorxiv : the Preprint Server for Biology|October 3, 2025
Differential migration mechanics and immune responses of glioblastoma subtypesGhaidan A Shamsan, Chao J Liu, Brooke C Braman, et al.
Molecular Biology of the Cell|April 7, 2017
Integrin-mediated traction force enhances paxillin molecular associations and adhesion dynamics that increase the invasiveness of tumor cells into a three-dimensional extracellular matrixArmen H Mekhdjian, FuiBoon Kai, Matthew G Rubashkin, et al.
Medrxiv : the Preprint Server for Health Sciences|January 4, 2023
Outpatient treatment of Covid-19 with metformin, ivermectin, and fluvoxamine and the development of Long Covid over 10-month follow-upCarolyn T Bramante, John B Buse, David Liebovitz, et al.
Open Forum Infectious Diseases|April 8, 2022
Vaccination Against SARS-CoV-2 Is Associated With a Lower Viral Load and Likelihood of Systemic SymptomsCarolyn T Bramante, Jennifer L Proper, David R Boulware, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 20, 2022
Impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccination and Booster on Coronavirus Disease 2019 (COVID-19) Symptom Severity Over Time in the COVID-OUT TrialDavid R Boulware, Thomas A Murray, Jennifer L Proper, et al.
Cancer Research|January 25, 2019
<i>Sleeping Beauty</i> Insertional Mutagenesis Reveals Important Genetic Drivers of Central Nervous System Embryonal TumorsPauline J Beckmann, Jon D Larson, Alex T Larsson, et al.
The Lancet. Infectious Diseases|June 11, 2023
Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trialCarolyn T Bramante, John B Buse, David M Liebovitz, et al.
The New England Journal of Medicine|September 7, 2022
Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19Carolyn T Bramante, Jared D Huling, Christopher J Tignanelli, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 2024
Favorable Antiviral Effect of Metformin on SARS-CoV-2 Viral Load in a Randomized, Placebo-Controlled Clinical Trial of COVID-19Carolyn T Bramante, Kenneth B Beckman, Tanvi Mehta, et al.
Medrxiv : the Preprint Server for Health Sciences|June 19, 2023
Metformin reduces SARS-CoV-2 in a Phase 3 Randomized Placebo Controlled Clinical TrialCarolyn T Bramante, Kenneth B Beckman, Tanvi Mehta, et al.
Pageof 12